Well Lead Medical Co., Ltd. (603309.SS)
CNY 10.87
(-0.09%)
CNY 10.87
(-0.09%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 238.83 Million CNY | 9.34% |
| 2022 | 206.65 Million CNY | 44.8% |
| 2021 | 142.71 Million CNY | -28.02% |
| 2020 | 198.26 Million CNY | 35.01% |
| 2019 | 146.85 Million CNY | 110.91% |
| 2018 | 69.62 Million CNY | -3.75% |
| 2017 | 72.33 Million CNY | -15.15% |
| 2016 | 85.25 Million CNY | -12.45% |
| 2015 | 97.37 Million CNY | 13.03% |
| 2014 | 86.14 Million CNY | 12.35% |
| 2013 | 76.67 Million CNY | 16.66% |
| 2012 | 65.72 Million CNY | 11.78% |
| 2011 | 58.8 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 68.39 Million CNY | 7.18% |
| 2024 Q1 | 59.38 Million CNY | 9.53% |
| 2024 Q2 | 63.81 Million CNY | 7.47% |
| 2023 Q3 | 55.75 Million CNY | 7.94% |
| 2023 Q2 | 51.65 Million CNY | -28.57% |
| 2023 FY | 225.96 Million CNY | 9.34% |
| 2023 Q1 | 72.31 Million CNY | 147.13% |
| 2023 Q4 | 54.21 Million CNY | -2.76% |
| 2022 FY | 206.65 Million CNY | 44.8% |
| 2022 Q3 | 73.09 Million CNY | 37.43% |
| 2022 Q2 | 53.18 Million CNY | 4.07% |
| 2022 Q1 | 51.1 Million CNY | 49.39% |
| 2022 Q4 | 29.26 Million CNY | -59.97% |
| 2021 Q4 | 34.21 Million CNY | -23.49% |
| 2021 Q1 | 31.07 Million CNY | 75.23% |
| 2021 FY | 142.71 Million CNY | -28.02% |
| 2021 Q2 | 32.71 Million CNY | 5.27% |
| 2021 Q3 | 44.71 Million CNY | 36.69% |
| 2020 Q4 | 17.73 Million CNY | -67.46% |
| 2020 Q2 | 107.69 Million CNY | 487.07% |
| 2020 Q1 | 18.34 Million CNY | -19.68% |
| 2020 FY | 198.26 Million CNY | 35.01% |
| 2020 Q3 | 54.49 Million CNY | -49.39% |
| 2019 Q2 | 59.31 Million CNY | 168.48% |
| 2019 FY | 146.85 Million CNY | 110.91% |
| 2019 Q1 | 22.09 Million CNY | -6.48% |
| 2019 Q4 | 22.83 Million CNY | -46.38% |
| 2019 Q3 | 42.59 Million CNY | -28.19% |
| 2018 Q2 | 19.88 Million CNY | 198.53% |
| 2018 Q3 | 19.46 Million CNY | -2.1% |
| 2018 Q4 | 23.62 Million CNY | 21.39% |
| 2018 FY | 69.62 Million CNY | -3.75% |
| 2018 Q1 | 6.65 Million CNY | -48.46% |
| 2017 FY | 72.33 Million CNY | -15.15% |
| 2017 Q4 | 12.92 Million CNY | -14.69% |
| 2017 Q3 | 15.14 Million CNY | -45.02% |
| 2017 Q1 | 16.72 Million CNY | -22.69% |
| 2017 Q2 | 27.54 Million CNY | 64.76% |
| 2016 Q1 | 16.65 Million CNY | -29.77% |
| 2016 Q4 | 21.62 Million CNY | -15.5% |
| 2016 FY | 85.25 Million CNY | -12.45% |
| 2016 Q3 | 25.59 Million CNY | 19.76% |
| 2016 Q2 | 21.37 Million CNY | 28.34% |
| 2015 Q3 | 33.42 Million CNY | 39.18% |
| 2015 Q1 | 16.22 Million CNY | -1.49% |
| 2015 FY | 97.37 Million CNY | 13.03% |
| 2015 Q4 | 23.71 Million CNY | -29.05% |
| 2015 Q2 | 24.01 Million CNY | 48.01% |
| 2014 Q2 | 26.78 Million CNY | 68.73% |
| 2014 Q4 | 16.46 Million CNY | -39.06% |
| 2014 Q1 | 15.87 Million CNY | 0.0% |
| 2014 FY | 86.14 Million CNY | 12.35% |
| 2014 Q3 | 27.02 Million CNY | 0.92% |
| 2013 FY | 76.67 Million CNY | 16.66% |
| 2012 FY | 65.72 Million CNY | 11.78% |
| 2011 FY | 58.8 Million CNY | 0.0% |